当前位置:首页 >英文主页 >中英对照 > 中译版报告详情

艾意凯咨询(L.E.K.):充分发挥高质量二代基因测序技术在亚太地区的潜力(2022)(中译版)(17页).pdf

上传人: Y**** 编号:106944 2022-11-21 17页 2.49MB

下载:

1、Recognizing the value of next-generation sequencing and call-to-action for its quality assurance and standardization.Unlocking the Value of QualityNext-Generation Sequencingin APACContents03 1 Contents02Unlocking the value of quality next-generation sequencing in APAC 04Unlocking the value of qualit

2、y next-generation sequencing in APAC 06Unlocking the value of quality next-generation sequencing in APAC 08Unlocking the value of quality next-generation sequencing in APAC 010Unlocking the value of quality next-generation sequencing in APAC 12Unlocking the value of quality next-generation sequencin

3、g in APAC 14Unlocking the value of quality next-generation sequencing in APAC 16Unlocking the value of quality next-generation sequencing in APAC 18Unlocking the value of quality next-generation sequencing in APAC 20Unlocking the value of quality next-generation sequencing in APAC Lack of standardiz

4、ation and quality in molecular testing procedures in APACNo consistency on how laboratories performing NGS tests are regulatedChallenge:In a large survey carried out by the IASLC,lack of quality and standardization was the second most frequent barrier for molecular testing in patients with lung canc

5、er in Asia after cost.57 Lack of standardization and quality can be further split into three aspects of NGS:processing of sample from patients,bioinformatic analysis of results and reporting of results.Processing of sample from patients:For instance,in the case of tissue samples,this included insuff

6、icient amount of tumor cells for testing(81%),inadequate tissue quality(52%),lack of sensitivity of assay or assay use failure(22%),and inadequate technical expertise in the laboratory(12%).Indeed,this study showed that 22Unlocking the value of quality next-generation sequencing in APAC 24Unlocking

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
本文主要讨论了下一代测序(NGS)在亚太地区(APAC)的质量保证和标准化的重要性。文章指出,尽管NGS技术在癌症诊断和治疗决策中具有变革性影响,但需要多利益相关者的观点来确保工作流程的优化、定制和数据分析的一致性。文章通过与Abbott、Guardant Health、Illumina、Janssen、Roche Diagnostics、Thermo Fisher Scientific和Vazyme等成员的合作,提出了针对APAC地区的定制化建议,以促进NGS测试的标准化和质量。 文章强调,NGS测试的质量至关重要,因为它可以提高患者结果并降低医疗系统的成本。例如,NGS测试可以提高患者对有效和个性化治疗方案的匹配,减少诊断时间并提供更准确的复发监测结果。此外,NGS测试可以提高医疗系统的成本效率,减少住院次数、住院时间、治疗成本或因使用不准确测试而造成的浪费。 文章还指出,目前许多APAC市场尚未为临床使用的NGS定义质量标准。因此,需要建立和执行NGS在APAC的质量标准。文章呼吁采取行动,为APAC地区的NGS设定质量标准。
下一代测序(NGS)在亚太地区的重要性是什么? NGS如何提高亚太地区患者的治疗效果和降低医疗成本? 亚太地区如何确保NGS测试的质量标准?
客服
商务合作
小程序
服务号
折叠